Skip to main content
Search

# de novo protein design

3 related articles

Subscribe to updates
  1. bioRxiv

    Heme hydroxylases no longer need natural scaffolds: computational design steers estradiol oxidation to C6 or C16

    A computational design pipeline builds heme peroxygenases from scratch, taking only a cysteine-ligated heme, a glutamate-histidine dyad that activates hydrogen peroxide, and a substrate positioned against the iron-oxo intermediate, so a hydroxylase can be tailored to a chosen C–H bond. On estradiol, two parallel campaigns directed oxidation to the benzylic C6 or the unactivated C16, giving initial yields below 1% but diastereomeric excess of 93% and 99%; targeted mutations on the C16 design raised estriol yield to 37% while keeping high selectivity.

  2. bioRxiv

    Latent generative search unlocks de novo design of untapped biomolecular interactions at scale

    This work introduces latent generative search for binder design, a framework that uses reward-guided search at inference time to steer the Proteina-Complexa generative model, which codesigns sequence and structure together in a continuous latent space and thereby removes the inverse-folding step; in a screen of more than one million designs by multiplexed phage display, it produced more validated binders than every other method tested, its codesigned sequences surpassed post hoc redesign, it delivered high-affinity binders across therapeutic receptors, a viral attachment protein and intracellular signalling targets, and it generated the first de novo proteins that bind a free carbohydrate, including one that discriminates between blood-group antigens.

  3. FEBS Letters

    Prospecting the Protein Design Landscape: From High-Affinity Binders to Functionally Switchable Proteins

    This review surveys the landscape of deep learning-driven protein design pipelines, discusses tailored applications in peptide, small molecule, binder, vaccine, and antibody design, argues that current confidence metrics for filtering and evaluating designs remain optimized for static protein interfaces and can fail on underrepresented or conformationally complex targets, proposes ensemble-based methods as a promising avenue for improving design success rates, and highlights emerging strategies such as fold-switching scaffolds and molecular glues realized through engineered cyclic peptides that expand the functional scope of designed proteins.

You’re all caught up